History of Absorbable Implants
In the US alone, there are over 2 million ortho fixation surgeries per year using titanium screw and plate implants, where 1 of every 4 patients suffer serious complications that lead to over $3B spent annually on implant removal surgeries. While permanent metal hardware in the body still accounts for 96% of the implant market, there is mounting dissatisfaction due to complications arising from infections, increased pain the longer the implants are in, and the common need for removal surgeries that are costly and lead to their own set of new complications and costs. Attempts have been made to develop absorbable implants, but early products performed poorly and surgeons have not adopted.
The Curasorb Difference
Our alloy is the first absorbable implant material that matches titanium’s performance and delivers optimal safe absorption. Implants made from this alloy will improve patient outcomes without increased complexity or expense, adding value to the healthcare system.
Curasorb is the first and only absorbable implant technology to offer the complete performance package that surgeons desire: the same implantation technique, cost and reliability of traditional metal implants, plus safe absorption that avoids inflammatory reactions and restores natural physiology, with reduced risk/cost of follow-up removal surgeries enabling improved financial positions for both hospitals and payors.
Patented IP for absorbable metal alloy; 100% ownership by Magsorbeo
Prototypes created and tested with highly favorable surgeon response
Positive preclinical study results
External validation of market approach, technology, and user requirements
(via in-depth surgeon interviews, hands-on evaluations including users of CE-marked absorbable metal implants, and target customer surveys)
Market Applications
Due to its specially engineered and adjustable absorption profile, our Curasorb alloy can be tailored to meet implant product needs across a variety of market applications. Magsorbeo’s beachhead market will be in Craniomaxillofacial (CMF) fixation where there is a strong unmet need for absorbable metal implants and a path to demonstrate early success with quick market share gains. Expansion from CMF into Extremities, Sports Medicine and Ortho Trauma further increase Curasorb's addressable implant market.